Species difference of 5-lipoxygenase derived from polymorphonuclear leukocytes on sensitivity to drugs

Jpn J Pharmacol. 1989 May;50(1):37-46. doi: 10.1254/jjp.50.37.

Abstract

Effects of 12 compounds including 5-lipoxygenase (5-LO) inhibitors and antiallergic drugs on the activity of 5-LO from the polymorphonuclear leukocytes (PMN) of guinea pigs, rats, rabbits, monkeys and humans were examined. The 5-LO activity was inhibited by the drugs according to the following orders of efficacy: Guinea pig 5-LO, 5-HDHDMF greater than TZI-2721 greater than NDGA greater than AA861 greater than FPL55712 greater than isoproterenol; rat 5-LO, 5-HDHDMF greater than AA861 greater than TZI-2721 greater than NDGA greater than FPL55712 greater than KP-136 greater than MCI-826 greater than benoxaprofen; and rabbit 5-LO, 5-HDHDMF greater than TZI-2721 greater than NDGA greater than AA861 greater than FPL55712 greater than KP-136 greater than MCI-826. The 5-LO activity from the rhesus monkey was dose-dependently inhibited by only 3 compounds, 5-HDHDMF greater than NDGA greater than TZI-2721, in this order, but the other compounds, except for AA861, did not show any effect on this activity. In humans, 5-LO activity was inhibited in the following order: TZI-2721 greater than 5-HDHDMF greater than NDGA greater than AA861 greater than FPL55712. From these results, it was strongly suggested that there is a species difference of this enzyme in its sensitivity to drugs.

MeSH terms

  • Animals
  • Arachidonate 5-Lipoxygenase / metabolism*
  • Arachidonate Lipoxygenases / metabolism*
  • Guinea Pigs
  • Humans
  • In Vitro Techniques
  • Indicators and Reagents
  • Lipoxygenase Inhibitors
  • Macaca mulatta
  • Male
  • Neutrophils / enzymology*
  • Rabbits
  • Rats
  • Rats, Inbred Strains
  • Species Specificity

Substances

  • Indicators and Reagents
  • Lipoxygenase Inhibitors
  • Arachidonate Lipoxygenases
  • Arachidonate 5-Lipoxygenase